Alzamend Neuro, Inc. (ALZN) Dividend History

Alzamend Neuro, Inc. (ALZN) is a biopharmaceutical company focused on developing innovative treatments for neurodegenerative and psychiatric disorders. The company's pipeline primarily includes therapies targeting conditions such as Alzheimer's disease, with an emphasis on novel approaches to address unmet medical needs in mental health and neurological health.

3500 Lenox Rd. Ne, Atlanta, GA, 30326
Phone: 844-722-6333
Website:

Dividend History

Alzamend Neuro, Inc. currently does not pay dividends

Company News

  • The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Aldeyra Therapeutics The Trade: Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) 10% owner Joseph Edelman acquired a total of 504,272 shares an average price of $3.84. To acquire these shares, it cost around $1.93 million. What’s Happening: On April ...

    Benzinga
    Featured Companies: ALDX RVP
  • The Dow Jones index closed lower by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Alzamend Neuro The Trade: Alzamend Neuro, Inc. (NASDAQ: ALZN) Director Milton C Ault III acquired a total of 2,000 shares an average price of $1.06. To acquire these shares, it cost around $2,127.. What’s Happening: On Dec. 11, 2023, Alzamend Neuro received a "Study May Proceed" letter from the FDA for the initiation of study AL001-PTSD01, a Phase 2A study of AL001 for post-traumatic stress disorder (PTSD). What ...

    Benzinga
    Featured Companies: AZTR GANX SILO
  • $1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying The Dow Jones index closed lower by over 150 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Fortress Biotech The Trade: Fortress Biotech, Inc. (NASDAQ: FBIO) President, CEO and Chairman MD Lindsay Rosenwald acquired a total of 50,000 shares an average price of $2.38. To acquire these shares, it cost around $118,770. What’s Happening: Fortress Biotech recently announced pricing of an $11 million registered direct offering priced at-the-market under Nasdaq rules. What Fortress Biotech Does: Fortress Biotech Inc is a ...

    Benzinga
    Featured Companies: FBIO VANI
  • Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the consensus of $1.28 billion. EPS of $0.49 surpassed the consensus of $0.48. For FY23, AEO revised guidance for revenue to be up mid-single digits Y/Y from growth in low single digits Y/Y earlier. American Eagle fell 16.4% to $16.52 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers Safe and Green Development Corporation (NASDAQ: SGD) shares gained 66% to $4.7119. Safe and Green Development unveiled a Letter of Intent for integration of real estate AI software. Mountain Crest Acquisition Corp. IV (NASDAQ: MCAF) shares jumped 52.4% to $9.92 after falling more than 12% on Monday. Anghami Inc. (NASDAQ: ANGH) shares jumped 36% to $2.1488. OSN Group announced up to $50 million cash investment in Anghami. TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) shares gained 27.9% to $0.2219. TRACON Pharmaceuticals recently announced license of product development platform for $3 million upfront payment. Marpai, Inc. (NASDAQ: MRAI) rose 24.2% to $1.1301. Marpai Form 4 filing showed Eitan Yaron bought 100,000 shares at an average price of $1.23 per share. Symbotic Inc. (NASDAQ: SYM) jumped 23.8% to $46.02 after the company reported better-than-expected fourth-quarter sales results. Burlington Stores, Inc. (NYSE: BURL) gained 19% to $162.77 after the company reported third-quarter financial results and issued guidance. Hibbett, Inc. (NASDAQ: HIBB) jumped 14.7% to $61.55 following strong quarterly sales. LQR House Inc. (NASDAQ: LQR) shares surged 14.5% to $0.0691. LQR House repurchased 1,476,355 shares in its ongoing share ...

    Benzinga
  • Shares of Symbotic Inc. (NASDAQ: SYM) surged in pre-market trading after the company reported better-than-expected fourth-quarter sales results. The company reported quarterly sales of $392.00 million which exceeded the analyst consensus estimate of $306.90 million. Symbotic reported quarterly losses of 8 cents per share, a 20% increase over losses of 10 cents per share from the same period last year, according to data from Benzinga Pro. Keybanc maintained Symbotic with an Overweight and raised the price target from $50 to $63. Symbotic shares gained 22% to $45.32 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) shares rose 65.9% to $0.2878 in pre-market trading. TRACON Pharmaceuticals recently announced license of product development platform for $3 million upfront payment. LQR House Inc. (NASDAQ: LQR) shares surged 62.5% to $0.0980 in pre-market trading. LQR House repurchased 1,476,355 shares in its ongoing share buyback initiative. Mountain Crest Acquisition Corp. IV (NASDAQ: MCAF) shares rose 41.2% to $9.20 in pre-market trading after falling more than 12% on Monday. Marpai, Inc. (NASDAQ: MRAI) rose 27.5% to $1.16 in pre-market trading. Marpai Form 4 filing showed Eitan Yaron bought 100,000 shares at an average price ...

    Benzinga
    Featured Companies: AORT SOPA SYM
Dividend data last updated 06/07/2025 20:38:50 UTC